Clinical trials
Diabetic clinical trials
Below are recruiting diabetic clinical trials, each written for real people, not researchers. We’re tracking 2,208 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06541535RecruitingPhase 4
Fluid treatment for severe diabetic ketoacidosis
This trial tests two types of fluids (saline or Ringer's lactate) to see which works better for people with severe diabetic ketoacidosis. Results could help doctors choose the best fluid replacement in this emergency.
NiceAges 18 years+ - NCT05756829Recruiting
Virtual education program for adults with type 1 diabetes
This study tests a 6-month online education and support program to help adults manage type 1 diabetes using insulin pump therapy or multiple daily insulin shots. It may help you improve understanding, day-to-day decision-making, and diabetes self-care with ongoing check-ins.
Kitchener, OntarioAges 18 years+ - NCT03925714RecruitingPhase 3
Testing a gene-related approach in people with prediabetes
This trial studies how changes involving p53 and SIRT1 may affect health in people with prediabetes. It may help researchers find better ways to stop or slow progression to type 2 diabetes.
CairoAges 18 years+ - NCT07630779RecruitingPhase 3
Alpha Lipoic Acid and Myo-Inositol for PCOS Without Diabetes
This study tests whether two natural supplements—alpha lipoic acid and myo-inositol—can help manage PCOS symptoms in women without diabetes. The trial aims to see if this combination improves insulin sensitivity and ovulation.
Cairo, Cairo GovernorateAges 21–40 - NCT07649317RecruitingPhase 1
Ketoconazole effects on cortisol rhythms in mild adrenal hormone changes
This study tests whether the drug ketoconazole can safely help regulate daily cortisol patterns in people with mild autonomous cortisol secretion (MACS), a condition where the adrenal glands make too much cortisol. It will compare how patients with MACS and healthy volunteers respond to the medication.
Bethesda, MarylandAges 18–100 - NCT07198789Recruiting
Low-sugar carbs for better fat and sugar levels
This study tests whether special carbohydrates that release sugar slowly (low glycemic index) can improve your blood fats (triglycerides) and other health markers better than regular whole grains. If you have moderately high triglycerides, this diet swap might help your metabolism and blood vessels.
Bologna, BOAges 18 years+ - NCT07496177RecruitingPhase 2
HTD1801 for kidney function in diabetes and kidney disease
This trial tests whether a new drug, HTD1801, can protect or improve kidney function in people with type 2 diabetes and chronic kidney disease. It may help slow kidney damage and reduce protein in urine.
Weifang, ShandongAges 18–75 - NCT06575868Recruiting
Can myo-inositol prevent gestational diabetes in pregnancy?
This study tests whether a supplement called myo-inositol (a natural sugar-like substance) can help prevent gestational diabetes in pregnant women with obesity. If you join, you will wear a continuous glucose monitor to track your blood sugar levels and might take the supplement or a placebo.
Boston, MassachusettsAges 18–45 - NCT07221045Recruiting
Food as medicine for food-insecure families in rural North Carolina
This study tests whether providing fresh produce boxes and nutrition classes helps families in rural North Carolina who struggle with food access. If you are a parent or caregiver of an 8–14-year-old and live in a participating county, you may qualify.
Raleigh, North CarolinaAges 8–64 - NCT07323901Enrolling by invitation
Grape juice for gestational diabetes screening
This study tests if a grape juice drink can be used instead of the standard sugary drink for gestational diabetes screening between weeks 24 and 28 of pregnancy. It might be a more natural and palatable option.
HaifaAges 18 years+ - NCT07229482Recruiting
Potatoes and your health: a 14-week food study
This study tests whether eating potatoes (as part of a provided diet) can improve blood sugar and heart health markers – possibly lowering your risk for type 2 diabetes.
Blacksburg, VirginiaAges 50–70 - NCT05862818Recruiting
Food timing study to see if it lowers diabetes risk
This study looks at whether changing when you eat can reduce the chance of developing diabetes. You’d need to be generally healthy and meet specific lifestyle and body-size requirements.
Boston, MassachusettsAges 18–45 - NCT07075978Enrolling by invitation
Mobile health study for chronic conditions
This study tests two ways of checking on your health at home: using a special device or having regular phone calls with a nurse. It's designed for people who already take medication for blood pressure or diabetes and have one of several chronic conditions.
Richmond, VirginiaAges 18 years+ - NCT06646107Recruiting
Mediterranean diet and insulin pump in type 1 diabetes
This trial tests whether following a Mediterranean diet can improve blood sugar control and insulin use in people with type 1 diabetes who are starting a new insulin pump (MiniMed 780G). It compares how diet affects glucose levels and insulin needs.
ChaïdáriAges 12–80 - NCT06706791RecruitingPhase 4
Empagliflozin for heart failure & diabetes: quality of life study
This trial tests whether a diabetes medicine called empagliflozin can improve the quality of life for people who have both chronic heart failure with a weak heart pump and type 2 diabetes. It compares the effects of adding empagliflozin to your current treatments.
Karachi, SindhAges 40–70 - NCT07347080RecruitingEarly Phase 1
Study of a new RNA-based drug for type 2 diabetes
This trial tests an experimental injection (CR059) for type 2 diabetes. It looks at safety and how the body handles different doses. You may qualify if you have had diabetes for 3 months to 5 years and are currently managing it with diet/exercise or certain diabetes pills.
Luoyang, HenanAges 18–65 - NCT06942195Recruiting
Calcium's effect on gut function and blood sugar in type 2 diabetes
This study tests if calcium can help control blood sugar and gut function in men with type 2 diabetes. You'll take calcium or a placebo and have a tube inserted into your stomach to measure digestion.
Adelaide, South AustraliaAges 18–70 - NCT06557057Recruiting
Aromatase inhibitors and diabetes risk in breast cancer
This study looks at how aromatase inhibitors, a type of hormone therapy for breast cancer, affect blood sugar and diabetes risk. It compares women taking these drugs to those on tamoxifen or healthy women, to see if there are changes in glucose control.
Rochester, MinnesotaAges Any age - NCT06492876RecruitingPhase 1/Phase 2
Gene therapy trial for diabetic macular edema (DME)
This trial tests a gene therapy for diabetic macular edema (DME), a condition where fluid builds up in the central part of the eye's retina. It aims to improve vision and reduce the need for frequent eye injections.
Tianjin, Tianjin,ChinaAges 18–74 - NCT06875193RecruitingPhase 4
Comparing dapagliflozin vs pioglitazone for type 2 diabetes
This study is testing two different diabetes pills—dapagliflozin or pioglitazone—in people with type 2 diabetes. The goal is to see which one works better when added to your current metformin and DPP-4 inhibitor. You may qualify if your blood sugar is not well controlled with your current medications.
SeoulAges 19 years+ - NCT07242664RecruitingPhase 1
Testing a new long-acting insulin in type 1 diabetes
This study compares a new investigational long-acting insulin (GZR33) to an approved one (insulin degludec) in people with type 1 diabetes. You would receive both insulins during an inpatient 'clamp' procedure to see how well they work, which may help find a more affordable or convenient option for daily blood sugar control.
NeussAges 18–64 - NCT07333313Recruiting
Study of oral medicine and probiotics for kidney disease in diabetes
This trial tests if an oral medication that absorbs toxins plus probiotics can reduce inflammation and slow kidney damage in people with diabetes-related kidney disease (DKD). It may help those with mild to severe kidney function loss.
Taipei, TaiwanAges 20 years+ - NCT06877975Recruiting
Testing a new device for glucose and ketone monitoring in healthy adults
This trial tests a new device that tracks blood sugar and ketone levels continuously. It is for healthy people aged 18–45 to see how well the device works.
Waterloo, OntarioAges 18–45 - NCT07532135RecruitingPhase 1
Mulberry leaf extract safety and blood sugar effects
This study tests whether a mulberry leaf supplement is safe and helps control blood sugar in people without diabetes. Researchers will monitor your health and blood work to see if this natural extract is beneficial.
BangkokAges 18 years+
Hear when a new Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetic?
- Yes. Clin2 currently lists 2,208 recruiting diabetic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.